Christensson A G, Grubb A O, Nilsson J-A, Norrgren K, Sterner G, Sundkvist G
Department of Nephrology and Transplantation, Malmö University Hospital, SE-205 02 Malmö, Sweden.
J Intern Med. 2004 Dec;256(6):510-8. doi: 10.1111/j.1365-2796.2004.01414.x.
To determine whether serum cystatin C is more accurate than serum creatinine in the detection of diabetic nephropathy, also after adjustment for age.
Forty-one patients with type 1 and 82 patients with type 2 diabetes were evaluated with serum creatinine, serum cystatin C, and (51)Cr-EDTA clearance (reference method). Cystatin C was measured by a particle-enhanced turbidimetric method and creatinine by an enzymatic method. Statistical estimations were performed both without and with age adjustment created by z-scores for (51)Cr-EDTA clearance, creatinine, and cystatin C. The cut-off levels for glomerular filtration rate (GFR) ((51)Cr-EDTA clearance) were 60 and 80 mL min(-1) 1.73 m(-2), respectively, in absolute values and 80, 90 and 95% CIs, respectively, in age-adjusted values (z-scores).
Estimations without age adjustment showed significantly (P = 0.0132) closer correlation for cystatin C (r = 0.817) versus (51)Cr-EDTA clearance as compared with creatinine (r = 0.678). However, when using age-adjusted values, the correlation for cystatin C and creatinine, respectively, versus (51)Cr-EDTA clearance did not differ. When comparing the diagnostic utilities for serum cystatin C versus serum creatinine in manifest renal impairment (GFR < 60 mL min(-1) 1.73 m(-2) or z-scores <-1.28 SD), there were no significant differences between the two markers whether age adjusted or not. However, for diagnosing mild nephropathy (GFR < 80 mL min(-1) 1.73 m(-2) or z-score -0.84 SD), serum cystatin C is significantly more useful.
Serum cystatin C performed better compared with serum creatinine even when measured enzymatically, to detect mild diabetic nephropathy. However, serum creatinine was as efficient as serum cystatin C to detect advanced diabetic nephropathy.
确定血清胱抑素C在检测糖尿病肾病方面是否比血清肌酐更准确,年龄校正后亦是如此。
对41例1型糖尿病患者和82例2型糖尿病患者进行血清肌酐、血清胱抑素C及(51)铬-乙二胺四乙酸清除率(参考方法)评估。胱抑素C采用颗粒增强比浊法测定,肌酐采用酶法测定。分别在未进行年龄校正以及通过(51)铬-乙二胺四乙酸清除率、肌酐和胱抑素C的z分数进行年龄校正的情况下进行统计估计。肾小球滤过率(GFR)((51)铬-乙二胺四乙酸清除率)的截断水平,绝对值分别为60和80 mL·min⁻¹·1.73 m⁻²,年龄校正值(z分数)分别为80、90和95%置信区间。
未进行年龄校正的估计显示,与肌酐(r = 0.678)相比,胱抑素C(r = 0.817)与(51)铬-乙二胺四乙酸清除率的相关性显著更高(P = 0.0132)。然而,使用年龄校正值时,胱抑素C和肌酐分别与(51)铬-乙二胺四乙酸清除率的相关性并无差异。比较血清胱抑素C和血清肌酐在显性肾功能损害(GFR < 60 mL·min⁻¹·1.73 m⁻²或z分数 < -1.28标准差)中的诊断效用时,无论是否进行年龄校正,两种标志物之间均无显著差异。然而,对于诊断轻度肾病(GFR < 80 mL·min⁻¹·1.73 m⁻²或z分数 < -0.84标准差),血清胱抑素C明显更有用。
即使采用酶法检测,血清胱抑素C在检测轻度糖尿病肾病方面也比血清肌酐表现更好。然而,血清肌酐在检测晚期糖尿病肾病方面与血清胱抑素C同样有效。